"Introducing a five-year screening programme for high-risk groups aged 45-69, using the current clinical pathway results in a positive socio-economic impact of £54m". This is one of the main claims of the Prostate Cancer Research report published today “Socio-economic impact of prostate cancer screening”, conducted by Deloitte. This analysis, in which Quibim has collaborated, highlights the economic and health benefits of improved screening practices to reduce healthcare costs and enhance patient outcomes. We were honored to attend the official launch in the House of Commons. Our thanks to Prostate Cancer Research (PCR), David Lammy Secretary of State for Foreign, Commonwealth and Development Affairs, James Cleverly Member of Parliament for the Braintree constituency and Josh Babarinde OBE CF MP of Parliament for Eastbourne for the invitation. We hope this report helps to elevate the importance of early #ProstateCancer screening.
At the Personalized Medicine Coalition conference, the conversations have been nothing short of inspiring. We could not be more grateful to the speakers that participated in "𝘛𝘳𝘢𝘯𝘴𝘧𝘰𝘳𝘮𝘪𝘯𝘨 𝘚𝘵𝘢𝘯𝘥𝘢𝘳𝘥-𝘰𝘧-𝘊𝘢𝘳𝘦 𝘐𝘮𝘢𝘨𝘪𝘯𝘨 𝘪𝘯𝘵𝘰 𝘗𝘳𝘦𝘤𝘪𝘴𝘪𝘰𝘯 𝘋𝘪𝘢𝘨𝘯𝘰𝘴𝘵𝘪𝘤𝘴" talk, where our CEO & Co-Founder Dr. Ángel Alberich-Bayarri had the chance to speak with Chiranjiv Singh, Megan Nacar and Okan Ekinci, MD MBA. A big thank you also to the panelists for the inspiring discussion on "𝘝𝘪𝘴𝘪𝘰𝘯𝘴 𝘧𝘰𝘳 𝘈𝘐 𝘢𝘯𝘥 𝘵𝘩𝘦 𝘍𝘶𝘵𝘶𝘳𝘦 𝘰𝘧 𝘗𝘦𝘳𝘴𝘰𝘯𝘢𝘭𝘪𝘻𝘦𝘥 𝘔𝘦𝘥𝘪𝘤𝘪𝘯𝘦," and to the PMC organization for this journey! #PMC #AIinHealthcare #PersonalizedMedicine #PrecisionMedicine
"Quibim? What an interesting name! Does it mean anything?" It might be one of the most frequently asked questions when we introduce ourselves. But since giving it all away wouldn't be much fun, we've prepared a little quiz with answers on the last slide! 👀 How many letters did you guess? #Quibim #MedicalImage #Quiz
Tomorrow, the annual Personalized Medicine Coalition conference will begin in Boston, and at Quibim, we are more than proud to be among the event's sponsors. Catch our team for lunch in our designated room 217 from 12:30 to 1:30 PM for the talk "𝘛𝘳𝘢𝘯𝘴𝘧𝘰𝘳𝘮𝘪𝘯𝘨 𝘚𝘵𝘢𝘯𝘥𝘢𝘳𝘥-𝘰𝘧-𝘊𝘢𝘳𝘦 𝘐𝘮𝘢𝘨𝘪𝘯𝘨 𝘪𝘯𝘵𝘰 𝘗𝘳𝘦𝘤𝘪𝘴𝘪𝘰𝘯 𝘋𝘪𝘢𝘨𝘯𝘰𝘴𝘵𝘪𝘤𝘴". During this session, renowned key industry leaders will explore how AI technologies can query the divergent effects of preventive and treatment interventions across a previously unimaginable range of data points. You can also engage with our CEO & Co-Founder, Dr Ángel Alberich-Bayarri, in the 4:30 PM panel discussion on "𝘝𝘪𝘴𝘪𝘰𝘯𝘴 𝘧𝘰𝘳 𝘈𝘐 𝘢𝘯𝘥 𝘵𝘩𝘦 𝘍𝘶𝘵𝘶𝘳𝘦 𝘰𝘧 𝘗𝘦𝘳𝘴𝘰𝘯𝘢𝘭𝘪𝘻𝘦𝘥 𝘔𝘦𝘥𝘪𝘤𝘪𝘯𝘦." Check out the full program at: https://lnkd.in/dzB6E7mM #PMC2024 #PersonalizedMedicine
🩺 From its contribution to cancer diagnoses to the effectiveness of screening methods in reducing mortality rates, radiology is integral to modern medicine, playing a critical role in diagnosing and managing diseases. On the occasion of #WorldRadiologyDay, we had the opportunity to interview Dr Jacob J. Visser, one of our advisors, to focus on advances in radiology technology and their implications for patient care. 👉 Read the full conversation here: https://lnkd.in/d_jXBHAQ #Radiology #Health #PatientCare #AIinHealth
🗓️ Mark your calendar for the Global Health Webinar on November 26, 2024. Organized by CERN Innovation Partnerships, this public event will reveal the results of its recent workshop, where health professionals, policymakers and experts addressed pressing global health challenges. Join this conversation to hear the conclusions that were drawn from plenty of speakers, included our CEO and co-founder, Ángel Alberich-Bayarri, who presented innovative ideas and potential collaborations to advance global health.
After the severe storms and flooding in Valencia, radiologists in the region and our CEO have spoken out about the impact in life and work. Read the full article here: https://lnkd.in/d4P5he-m
Sir Chris Hoy, six-time Olympic champion, has shared his terminal diagnosis of #ProstateCancer with a powerful message: initiate early screening for men with a strong family history. “Catch it before they need major treatment,” he urges to lower the age of detection to save lives. This call comes at an opportune time, as the largest prostate cancer screening trial in 20 years, the TRANSFORM trial, is underway in the UK. This initiative is an ambitious effort to determine the most effective #screening methods and offers a critical opportunity to reshape early detection. ➡️ https://lnkd.in/dQxJV5vu
October is always a key month. Here are some of the highlights that we shared these last weeks: 🌐 The launch of our website in Spanish and French! 🩷 Breast Cancer Awareness Month: the MASAI trial has recently proven that AI can cut radiologists' workload by 44% 💡 QP-Prostate helps radiologists detect over 90% of prostate cancer cases in Spain Stay up to date on #AI, #Radiomics, and #CancerCare in our newsletter - subscribe now!
Many of you have asked how to help the victims of the severe storms and flooding these days in Valencia. Here’s a list of organizations and associations actively providing assistance on the ground:
